Delcath Systems (FRA:DV3R) Accounts Payable : €1.37 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems Accounts Payable?

Delcath Systems's Accounts Payable for the quarter that ended in Mar. 2024 was €1.37 Mil.

Delcath Systems's quarterly Accounts Payable increased from Sep. 2023 (€0.71 Mil) to Dec. 2023 (€0.93 Mil) and increased from Dec. 2023 (€0.93 Mil) to Mar. 2024 (€1.37 Mil).

Delcath Systems's annual Accounts Payable increased from Dec. 2021 (€0.57 Mil) to Dec. 2022 (€1.91 Mil) but then declined from Dec. 2022 (€1.91 Mil) to Dec. 2023 (€0.93 Mil).

Delcath Systems Accounts Payable Historical Data

The historical data trend for Delcath Systems's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Accounts Payable Chart

Delcath Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

4.08

1.46

0.57

1.91

0.93

Delcath Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															2.27	0.89	0.71	0.93	1.37

Delcath Systems Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Delcath Systems Accounts Payable Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems (FRA:DV3R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

DCTH:USA

Address

1633 Broadway, Suite 22C, New York, NY, USA, 10019

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines